Location History:
- New York, NY (US) (2015 - 2019)
- Seattle, WA (US) (2020 - 2023)
Company Filing History:
4 out of 559 
2 out of 289 
Years Active: 2015-2025
Title: The Innovative Contributions of Jarrod Dudakov
Introduction
Jarrod Dudakov is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of stem cell research, holding a total of 5 patents. His work focuses on the use of luteinizing hormone receptor binding agents and agonists to enhance the therapeutic potential of hematopoietic stem cells.
Latest Patents
Dudakov's latest patents include innovative methods that utilize luteinizing hormone receptor (LHR) binding agents and luteinizing hormone (LH) agonists. These methods aim to enrich primitive hematopoietic stem cell (pHSC) populations, target them for ablation, and expand their populations. The applications of these methods are crucial for preparing therapeutic hematopoietic stem cell (HSC) populations, facilitating HSC transplants, and treating malignancies associated with hyperproliferative HSC.
Career Highlights
Throughout his career, Dudakov has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and Fred Hutchinson Cancer Center. His research has significantly advanced the understanding and application of stem cell therapies.
Collaborations
Dudakov has collaborated with notable colleagues, including Marcel Van Den Brink and Enrico Velardi. These partnerships have further enriched his research and contributions to the field.
Conclusion
Jarrod Dudakov's innovative work in stem cell research and his numerous patents highlight his dedication to advancing medical science. His contributions are paving the way for new therapeutic approaches in treating various malignancies.